Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study

BACKGROUND: Hydroxychloroquine (HCQ) is a well-known immunomodulator that was recently used in immunoglobulin A (IgA) nephropathy (IgAN) due to its antiproteinuric effects. We investigated the effects of HCQ in patients with IgAN whose proteinuria remained above 1 g/d after conventional immunosuppre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Chen, Lv, Ji-Cheng, Shi, Su-Fang, Chen, Yu-Qing, Liu, Li-Jun, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653892/
https://www.ncbi.nlm.nih.gov/pubmed/33172397
http://dx.doi.org/10.1186/s12882-020-02141-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653892/
https://www.ncbi.nlm.nih.gov/pubmed/33172397
http://dx.doi.org/10.1186/s12882-020-02141-9

Ejemplares similares